Back to the Top News Newsfeed

Immunovant, Inc. (IMVT): Is It The Most Oversold Healthcare Stock to Buy Now?

Related Topics: Immunovant

IMVT +4.01%

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Immunovant, Inc. (NASDAQ:IMVT) stands against the other oversold healthcare stocks.

Are Healthcare Costs Rising in the US?

Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022. The healthcare sector accounted for around 17.